Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ballentine Carter

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Asian Journal of Andrology|February 21, 2012
Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kineticsH Ballentine Carter
The Journal of Urology|November 17, 2009
Editorial commentH Ballentine Carter
Urology|September 1, 2009
Editorial commentH Ballentine Carter
Journal of the National Cancer Institute|April 20, 2006
Assessing risk: does this patient have prostate cancer?H Ballentine Carter
The Journal of Urology|March 2, 2019
Editorial CommentH Ballentine Carter
European Urology|July 15, 2014
Reducing prostate cancer deaths: unsupported speculation about the androgen deprivation hypothesisH Ballentine Carter
Journal of the National Cancer Institute. Monographs|December 29, 2012
Active surveillance for prostate cancer: an underutilized opportunity for reducing harmH Ballentine Carter
The Johns Hopkins Medical Letter Health After 50|January 31, 2008
Consultation corner. Prostate screening: refining what PSA levels meanH Ballentine Carter
Urology|February 1, 2003
Informed consent for prostate-specific antigen screeningH Ballentine Carter
Urology|July 2, 2009
Editorial commentH Ballentine Carter
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Asian Journal of Andrology|February 21, 2012
Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kineticsH Ballentine Carter
The Journal of Urology|November 17, 2009
Editorial commentH Ballentine Carter
Urology|September 1, 2009
Editorial commentH Ballentine Carter
Journal of the National Cancer Institute|April 20, 2006
Assessing risk: does this patient have prostate cancer?H Ballentine Carter
The Journal of Urology|March 2, 2019
Editorial CommentH Ballentine Carter
European Urology|July 15, 2014
Reducing prostate cancer deaths: unsupported speculation about the androgen deprivation hypothesisH Ballentine Carter
Journal of the National Cancer Institute. Monographs|December 29, 2012
Active surveillance for prostate cancer: an underutilized opportunity for reducing harmH Ballentine Carter
The Johns Hopkins Medical Letter Health After 50|January 31, 2008
Consultation corner. Prostate screening: refining what PSA levels meanH Ballentine Carter
Urology|February 1, 2003
Informed consent for prostate-specific antigen screeningH Ballentine Carter
Urology|July 2, 2009
Editorial commentH Ballentine Carter
Pageof 21